Key Takeaways:
Impact Therapeutics-B (07630.HK) surged 117.7% in its Hong Kong trading debut, closing the morning session at $43.76 per share.
The biopharmaceutical company’s shares opened at $35.5, already 76.6% above the initial public offering price of $20.1. The stock traded within a range of $33.1 and $45 during the morning session. Trading was active, with 12.64 million shares changing hands, resulting in a total turnover of $439.91 million.
The strong performance indicates significant investor appetite for pharmaceutical newcomers on the Hong Kong exchange. The debut's success gives the company a strong start in the public market, with its valuation now being tested by open market dynamics. Investors will watch if the momentum can be sustained in the afternoon session and beyond.
This article is for informational purposes only and does not constitute investment advice.
